These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 35577037)
1. Development of (Inhalable) Dry Powder Formulations of AS01 AboulFotouh K; Xu H; Moon C; Williams RO; Cui Z Int J Pharm; 2022 Jun; 622():121825. PubMed ID: 35577037 [TBL] [Abstract][Full Text] [Related]
2. Formulation of dry powders of vaccines containing MF59 or AddaVax by Thin-Film Freeze-Drying: Towards a dry powder universal flu vaccine. AboulFotouh K; Uno N; Xu H; Moon C; Sahakijpijarn S; Christensen DJ; Davenport GJ; Cano C; Ross TM; Williams Iii RO; Cui Z Int J Pharm; 2022 Aug; 624():122021. PubMed ID: 35842082 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of intranasal delivery of thin-film freeze-dried, mucoadhesive vaccine powders. Yu YS; AboulFotouh K; Xu H; Williams G; Suman J; Cano C; Warnken ZN; Wu KC; Williams RO; Cui Z Int J Pharm; 2023 Jun; 640():122990. PubMed ID: 37127138 [TBL] [Abstract][Full Text] [Related]
4. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution. Li X; Thakkar SG; Ruwona TB; Williams RO; Cui Z J Control Release; 2015 Apr; 204():38-50. PubMed ID: 25735896 [TBL] [Abstract][Full Text] [Related]
5. Reconstituted dry powder formulations of ZnO-adjuvanted ovalbumin induce equivalent antigen specific antibodies but lower T cell responses than ovalbumin adjuvanted with Alhydrogel® or cationic adjuvant formulation 01 (CAF®01). Hellfritzsch M; Christensen D; Foged C; Scherließ R; Thakur A Int J Pharm; 2023 Dec; 648():123581. PubMed ID: 37931728 [TBL] [Abstract][Full Text] [Related]
6. Dry powders for inhalation containing monoclonal antibodies made by thin-film freeze-drying. Hufnagel S; Xu H; Sahakijpijarn S; Moon C; Chow LQM; Williams Iii RO; Cui Z Int J Pharm; 2022 Apr; 618():121637. PubMed ID: 35259440 [TBL] [Abstract][Full Text] [Related]
7. Thin-Film Freeze-Drying Is a Viable Method to Convert Vaccines Containing Aluminum Salts from Liquid to Dry Powder. Alzhrani RF; Xu H; Moon C; Suggs LJ; Williams RO; Cui Z Methods Mol Biol; 2021; 2183():489-498. PubMed ID: 32959262 [TBL] [Abstract][Full Text] [Related]
8. Aerosolizable siRNA-encapsulated solid lipid nanoparticles prepared by thin-film freeze-drying for potential pulmonary delivery. Wang JL; Hanafy MS; Xu H; Leal J; Zhai Y; Ghosh D; Williams Iii RO; David Charles Smyth H; Cui Z Int J Pharm; 2021 Mar; 596():120215. PubMed ID: 33486021 [TBL] [Abstract][Full Text] [Related]
9. Thin-film freeze-drying of a bivalent Norovirus vaccine while maintaining the potency of both antigens. Xu H; Bhowmik T; Gong K; Huynh TNA; Williams RO; Cui Z Int J Pharm; 2021 Nov; 609():121126. PubMed ID: 34560208 [TBL] [Abstract][Full Text] [Related]
10. The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures. Thakkar SG; Ruwona TB; Williams RO; Cui Z Hum Vaccin Immunother; 2017 Apr; 13(4):936-946. PubMed ID: 28051903 [TBL] [Abstract][Full Text] [Related]
11. Manufacturing Stable Bacteriophage Powders by Including Buffer System in Formulations and Using Thin Film Freeze-drying Technology. Zhang Y; Soto M; Ghosh D; Williams RO Pharm Res; 2021 Oct; 38(10):1793-1804. PubMed ID: 34697726 [TBL] [Abstract][Full Text] [Related]
12. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application. Maa YF; Zhao L; Payne LG; Chen D J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382 [TBL] [Abstract][Full Text] [Related]
13. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01. Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813 [TBL] [Abstract][Full Text] [Related]
14. Inhalable dry powders of microRNA-laden extracellular vesicles prepared by thin-film freeze-drying. AboulFotouh K; Almanza G; Yu YS; Joyce R; Davenport GJ; Cano C; Williams Iii RO; Zanetti M; Cui Z Int J Pharm; 2024 Feb; 651():123757. PubMed ID: 38160992 [TBL] [Abstract][Full Text] [Related]
15. Thin-film freeze-drying of an influenza virus hemagglutinin mRNA vaccine in unilamellar lipid nanoparticles with blebs. Li Q; Shi R; Xu H; AboulFotouh K; Sung MMH; Oguin TH; Hayes M; Moon C; Dao HM; Ni H; Sahakijpijarn S; Cano C; Davenport GJ; Williams RO; Le Huray J; Cui Z; Weissman D J Control Release; 2024 Nov; 375():829-838. PubMed ID: 39293526 [TBL] [Abstract][Full Text] [Related]
16. Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying. Zhang H; Zhang Y; Williams RO; Smyth HDC Int J Pharm; 2021 Aug; 605():120831. PubMed ID: 34175380 [TBL] [Abstract][Full Text] [Related]
17. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation. Saluja V; Amorij JP; Kapteyn JC; de Boer AH; Frijlink HW; Hinrichs WL J Control Release; 2010 Jun; 144(2):127-33. PubMed ID: 20219608 [TBL] [Abstract][Full Text] [Related]
18. Preparation of redispersible liposomal dry powder using an ultrasonic spray freeze-drying technique for transdermal delivery of human epithelial growth factor. Yin F; Guo S; Gan Y; Zhang X Int J Nanomedicine; 2014; 9():1665-76. PubMed ID: 24729702 [TBL] [Abstract][Full Text] [Related]
19. Liposomal dry powders as aerosols for pulmonary delivery of proteins. Lu D; Hickey AJ AAPS PharmSciTech; 2005 Dec; 6(4):E641-8. PubMed ID: 16408866 [TBL] [Abstract][Full Text] [Related]
20. Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate. Gomez M; McCollum J; Wang H; Ordoubadi M; Jar C; Carrigy NB; Barona D; Tetreau I; Archer M; Gerhardt A; Press C; Fox CB; Kramer RM; Vehring R Int J Pharm; 2021 Jan; 593():120121. PubMed ID: 33278492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]